Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations
Background . Available treatments for Wilson disease (WD) prevent longterm complications of copper accumulation. Current anti-copper agents include zinc salts, penicillamine, and trientine. Patients with WD may switch between the agents for a number of reasons. Due to the different mechanisms of act...
Main Authors: | Marcia Leung MD, Jaimie Wu Lanzafame MD, Valentina Medici MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-01-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709619896876 |
Similar Items
-
Lipid and energy metabolism in Wilson disease
by: Tagreed A. Mazi, et al.
Published: (2020-03-01) -
Wilson Disease: Case Report
by: Esra Tuğ, et al.
Published: (2007-01-01) -
Wilson disease: At the crossroads between genetics and epigenetics—A review of the evidence
by: Dorothy A. Kieffer, et al.
Published: (2017-09-01) -
Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
by: Valentina Medici, et al.
Published: (2021-08-01) -
WILSON'S DISEASE IN CHILDREN, REPORT OF 25 CASES
by: Y. AGHIGHI, et al.
Published: (1984-12-01)